This inventor holds 1 USPTO granted patent. Top assignees: Dainippon Pharmaceutical Company, Limited, Laboratoire Roger Bellon. Active years: 1984.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1984
Title: Hitoshi Ichihashi: Innovator in Pharmaceutical Compounds
Introduction
Hitoshi Ichihashi is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on naphthyridine derivatives. His research has led to advancements that enhance the stability and efficacy of pharmaceutical compounds.
Latest Patents
Ichihashi holds a patent for the "Sesquihydrate of naphthyridine derivative, and process for the - Novel 1-ethyl-6-fluoro-1,4-dihydro-4-oxo -7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid.sesquihydrate." This compound can be prepared by heating 1-ethyl-6-fluoro-1,4-dihydro-4-oxo -7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid at a temperature above about 60°C in the presence of water. The resulting sesquihydrate is much more stable than its anhydrate and trihydrate counterparts. It also exhibits superior rates of dissolution and transference into the body through the intestines, making it especially useful as a pharmaceutical compound. Ichihashi has 1 patent to his name.
Career Highlights
Throughout his career, Ichihashi has worked with prominent organizations, including Dainippon Pharmaceutical Company, Limited and Laboratoire Roger Bellon. His work has been instrumental in developing new pharmaceutical solutions that address various medical needs.
Collaborations
Ichihashi has collaborated with notable colleagues such as Terukazu Tanaka and Yu Imasato. These partnerships have contributed to the advancement of his research and the successful development of innovative pharmaceutical compounds.
Conclusion
Hitoshi Ichihashi is a distinguished inventor whose work in pharmaceutical compounds has made a significant impact in the field. His innovative approaches and collaborations continue to influence the development of effective medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile